Takeda sells off another OTC asset for $2.2B

Takeda sold its Japanese-focused consumer healthcare business to private equity firm Blackstone Group for $2.2 billion, the latest in several similar transactions the company has executed, Endpoints News reports.

Advertisement

What you should know:

1. Takeda spun off several of its non-core business lines after closing its deal for Shire in 2019. The company has committed to selling $10 billion of its non-core assets.

2. Takeda acquired Shire for $62 billion, which made it one of the most indebted companies in the world.

3. Blackstone acquired a portfolio of drugs that made a reported $567 million (60 billion yen) in 2019.

More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.